KRESSA SCHUETT: Open Payments
NPI 1164832085 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 38 payments from 17 companies in 2025. Trend: 2023 $973 · 2024 $898 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $155 |
| Merck Sharp & Dohme LLC | 4 | $99 |
| GENZYME CORPORATION | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| ABBVIE INC. | 2 | $49 |
| Baxter Healthcare | 2 | $46 |
| Aimmune Therapeutics, Inc. | 1 | $43 |
| Amgen Inc. | 2 | $35 |
Products named: DUPIXENT, WINREVAIR, NUCALA, TEZSPIRE, Hillrom - Vest System Model 105 Home Care, ZENPEP, FASENRA, Prolastin-C Liquid.
Industry payments across AR — which companies pay providers there.
